Latest filing published 17 Jun 2020 for Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.), €787.
All filings by Jesse Francis Ledger on record concern Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.). Over a trading history stretching from 4 April 2016 to 16 June 2020, the count stands at 44 filings.
The open-market record is one-sided, with 42 purchases worth €44k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. Since January 2020: 27 purchases and no sales on the market.
Half of the purchases are above €1,255 and half below. None of the 42 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 17 June 2020 came the latest disclosure, an open-market purchase for €787 in Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.). The median gap between a trade and its publication by SEDI is 1 day. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 44 declarations